<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00433342</url>
  </required_header>
  <id_info>
    <org_study_id>ML3532</org_study_id>
    <nct_id>NCT00433342</nct_id>
  </id_info>
  <brief_title>The Effect of Antimicrobial Therapy on the Serum Level of P-cresol in Peritoneal Dialysis Patients</brief_title>
  <official_title>Study on the Effect of Flucloxacillin on the Serum Level of P-cresol in Peritoneal Dialysis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      An important subgroup of protein-bound toxins are generated as a result of protein
      fermentation in the colon. P-cresol is a fermentation metabolite of tyrosine. In renal
      failure, the colonic generation rate of p-cresol is markedly elevated. After absorption, the
      majority of p-cresol is conjugated to form p-cresyl sulphate. There is clear evidence, both
      in vitro and in vivo, that accumulation of conjugated fermentation metabolites is correlated
      with clinical important endpoints. Free p-cresol is an independent predictor for mortality in
      hemodialysis patients.

      Moreover, in renal failure patients, neither hemodialysis nor peritoneal dialysis is capable
      of normalising the clearly elevated serum concentrations of p-cresyl sulphate. Removal is at
      least partially diminished by the important protein binding of p-cresol. Besides adaptation
      of renal replacement therapies to improve removal of protein bound solutes, another approach
      is to lower the generation of uremic toxins.

      The mechanisms underlying colonic carbohydrate and protein fermentation, responsible for the
      generation of p-cresol, are only partially understood. On the one hand, the ratio of
      fermentable carbohydrates to proteins has been shown to be an important determinant of
      protein fermentation. On the other hand, changes in the colonic bacterial flora influence the
      generation of p-cresol in dogs and in healthy human individuals.

      The effect of antibiotic therapy on bacterial protein fermentation and thus on the generation
      of p-cresol is not known. A reanalysis of data abstracted from a recent longitudinal study in
      peritoneal dialysis (PD) patients suggests that antibiotic therapy may lower p-cresol levels
      substantially. The current study aims at confirming these data in a prospective manner.
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <start_date>March 2006</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>p-cresol reduction rate</measure>
    <time_frame>8 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Chronic Kidney Disease</condition>
  <arm_group>
    <arm_group_label>I</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Flucloxacillin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>II</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Flucloxacillin</intervention_name>
    <description>500 mg QD oral</description>
    <arm_group_label>I</arm_group_label>
    <other_name>Floxapen</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18

          -  Exit site infection, requiring antibiotic treatment

          -  Maintenance therapy with peritoneal dialysis

        Exclusion Criteria:

          -  Signs of peritonitis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Björn Meijers, MD</last_name>
    <role>Study Chair</role>
    <affiliation>UZ Leuven</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pieter Evenepoel, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>UZ Leuven</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universitaire Ziekenhuizen Leuven</name>
      <address>
        <city>Leuven</city>
        <state>Vlaams-Brabant</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>Bammens B, Evenepoel P, Keuleers H, Verbeke K, Vanrenterghem Y. Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int. 2006 Mar;69(6):1081-7.</citation>
    <PMID>16421516</PMID>
  </reference>
  <verification_date>September 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 7, 2007</study_first_submitted>
  <study_first_submitted_qc>February 8, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 9, 2007</study_first_posted>
  <last_update_submitted>September 14, 2011</last_update_submitted>
  <last_update_submitted_qc>September 14, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 15, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitaire Ziekenhuizen Leuven</investigator_affiliation>
    <investigator_full_name>Björn Meijers</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>Antibiotic</keyword>
  <keyword>p-cresol</keyword>
  <keyword>peritoneal dialysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Floxacillin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

